References
Augustin A (2010) Dev Ophthalmol 47:10–26
Boyer DS et al (2014) Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 4 June, Pii: S0161-6420(14)00378-9
Edelman J (2010) Differentiating intraocular glucocorticoids. Ophthalmologica 224:25–30
Eljarrat-Bienstock E, Pe’er J, Domb AJ (2010) New techniques for drug delivery to the posterior eye segment. Pharm Res 27:530–543
Ford JA et al (2013) Current treatments in diabetic macular edema: a systematic review and meta-analysis. BMJ Open 3:e002269
Girach A, Lund-Andersen H (2007) Diabetic macular oedema: a clinical overview. Int J Clin Pract 61:88–97
Golan S, Loewenstein A (2010) Steroids and the management of macular edema. Ophthalmologica 224(suppl 1):31–40
Guigou S et al (2014) Multicenter Ozurdex ® assessment for diabetic macular edema: MOZART study. J Fr Ophthalmol 37(6):480–485
Kanski JJ (2008a) Clinical ophthalmology, 6th edn. Elsevier, Munich, pp 581–606
Kanski JJ (2008b) Clinical ophthalmology, 6th edn. Elsevier, Munich, pp 452–462
Kearns VR, Williams RL (2009) Drug delivery systems for the eye. Expert Rev Med Devices 6:277–290
Kiernan DF, Mieler WF (2009) The use of intraocular steroids. Expert Opin Pharmacother 10:2511–2525
Kumar P, Clark M (2009) Clinical medicine, 7th edn. Saunders Elsevier
Kuno N, Fujii S (2010) Biodegradable intraocular therapies for retinal disorders. Drugs Aging 27:117–134
Kuppermann BD, Loewenstein A (2010) Drug delivery to the posterior segment of the eye. In: Coscas G (ed) Macular edema, vol 47, Developments in ophthalmology. Karger, Basel, pp 59–72
Lee SS, Hughes P, Ross AD, Robinson MR (2010) Biodegradable implants for sustained drug release in the eye. Pharm Res 27:2043–2053
Marieb E, Hoehn K (2007) Human anatomy and physiology, 7th edn. Pearson International Edition
Ozurdex Summary of Product Characteristics (2013) Allergan Ltd, 28 May 2013. Source: http://www.medicines.org.uk/emc/print-document?documentId=23422
Pasqualetti G, Danesi R, Del Tacca M, Bocci G (2007) Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy. Pharmacogenomics 8:49–66
Saishin Y et al (2003) Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier. J Cell Physiol 195:210–219
Taylor RJ, Hazlita I (2010) New developments in corticosteroid therapy for uveitis. Ophthalmologica 224(Suppl 1):46–53
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Kuppermann, B. (2015). Dexamethasone Implant. In: Schmidt-Erfurth, U., Kohnen, T. (eds) Encyclopedia of Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35951-4_1132-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-35951-4_1132-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-35951-4
eBook Packages: Springer Reference MedicineReference Module Medicine